Who are Gennao Bio's investors?

Gennao Bio's investors include OrbiMed.

How much funding has Gennao Bio raised?

Gennao Bio has disclosed $47.5M raised across 2 rounds.

Where is Gennao Bio headquartered?

Gennao Bio is headquartered in Pennington, US.

Gennao Bio

Pennington, US · Founded 2020 · Delaware corporation · 1 known investors

Find your way into Gennao Bio

Each arrow is one introduction. Sign up to fill in the first one.

262 people can intro you to Chris

Ask Elias Quijano to introduce you to Chris Duke

You →Elias · together at Gennao Bio →Chris

185 people can intro you to Anuj

Ask Jamie Chen to introduce you to Anuj Goswami

You →Jamie · together at Gennao Bio →Anuj

129 people can intro you to Claudine

Ask Sam Okafor to introduce you to Claudine Prowse

You →Sam · together at Gennao Bio →Claudine

Your email: who you already know at Gennao Bio, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Gennao Bio team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Genetic medicines company developing targeted nucleic acid therapeutics via a gene monoclonal antibody platform.

Biotech

Founders & leadership

Chris Duke Chief Executive Officer2022–2025Chief Operating Officer of Gennao Bio, Chris Duke brings 15 years of experience in rare diseases and immuno-oncology spanning development and commercialization, including six years of global commercial leadership across North America, Europe, and Asia-Pacific, as well as clinical development oversight for immuno-oncology programs.

Dale LudwigMr. Ludwig is the Chief Scientific Officer

Anuj Goswami General Counsel2021–2025General Counsel and Secretary at Gennao Bio, where he has overseen equity financings and established governance and intellectual property frameworks. Goswami has served on the board of Suvoda LLC and provided advisory services on large debt finance transactions.

Claudine Prowse Chief Financial Officer2021–2023She previously held CFO and operating roles at several biotech firms including Biogen, Human Genome Sciences, Rocket Pharma, and Ionis Pharmaceuticals, and holds a Ph.D. in Biochemistry from UC San Diego and a B.S. in Bioengineering from UCSD.

Gary SenderNamed on SEC filing

Julie HambletonNamed on SEC filing

Bruce TurnerNamed on SEC filing

Board

Chau Khuong Board directorAdvisory Board; Founder & Chief Investment Officer, CJNV BioVentures at Blackbird Bioventures

Stephen Squinto Executive Chairman2021–2022Venture Partner at OrbiMed

Investors · 1

OrbiMedlisted by OrbiMedNew York · $1M – $75Mvia Chau Khuong · board

How we know: OrbiMed's portfolio page · board seat on SEC Form D · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$47.5M disclosed across 2 rounds · 2021–2022

▶$15MraisedDec 2022 · 3 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Julie HambletonDirector
Anuj GoswamiExecutive Officer
Claudine ProwseExecutive Officer
Joe McIntoshExecutive Officer
Bradley CampbellDirector
Craig GordonDirector
Stephen SquintoExecutive Officer, Director, Promoter
Peter ThompsonDirector
Dale LudwigExecutive Officer
Chris DukeExecutive Officer
Gary SenderDirector

Offering amount: $40M
Amount sold: $15M
First sale: Nov 2022
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$32.5MraisedDec 2021 · 7 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Chris DukeExecutive Officer
Chau KhuongDirector
Gary SenderDirector
Stephen SquintoExecutive Officer, Director, Promoter
Dale LudwigExecutive Officer
Julie HambletonDirector
Anuj GoswamiExecutive Officer
Claudine ProwseExecutive Officer
Bruce TurnerDirector

Offering amount: $55M
Amount sold: $32.5M
First sale: May 2021
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Gennao Bio do?: Genetic medicines company developing targeted nucleic acid therapeutics via a gene monoclonal antibody platform.
Who are Gennao Bio's investors?: Gennao Bio's investors include OrbiMed.
How much funding has Gennao Bio raised?: Gennao Bio has disclosed $47.5M raised across 2 rounds.
Where is Gennao Bio headquartered?: Gennao Bio is headquartered in Pennington, US.